Home NDC 16714-860-01 Atazanavir Sulfate
Product NDC 16714-860
Requested package NDC 16714-860-01
11-digit product format 167140860
Labeler code 16714
Product ID 16714-860_c5ff6121-ec6c-49b4-a722-81feecbb0bb5
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Atazanavir
Dosage form CAPSULE
Route ORAL
Labeler NorthStar Rx LLC
Application ANDA204806
Marketing category ANDA
Marketing start 2019-04-08
Marketing end 0000-00-00
Substance ATAZANAVIR SULFATE
Active strength 150 mg/1
Pharmacologic classes HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],UGT1A1 Inhibitors [MoA],UDP Glucuronosyltransferases Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2021-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 12 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A204806-001 ATAZANAVIR SULFATE ATAZANAVIR SULFATE EQ 100MG BASE CAPSULE / ORAL AB 2018-06-25 A204806-002 ATAZANAVIR SULFATE ATAZANAVIR SULFATE EQ 150MG BASE CAPSULE / ORAL AB 2018-06-25 A204806-003 ATAZANAVIR SULFATE ATAZANAVIR SULFATE EQ 200MG BASE CAPSULE / ORAL AB 2018-06-25 A204806-004 ATAZANAVIR SULFATE ATAZANAVIR SULFATE EQ 300MG BASE CAPSULE / ORAL AB 2018-06-25
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 4 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 164 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A204806-001 ATAZANAVIR SULFATE EQ 100MG BASE CAPSULE / ORAL AB 2018-06-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A204806-002 ATAZANAVIR SULFATE EQ 150MG BASE CAPSULE / ORAL AB 2018-06-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A204806-003 ATAZANAVIR SULFATE EQ 200MG BASE CAPSULE / ORAL AB 2018-06-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A204806-004 ATAZANAVIR SULFATE EQ 300MG BASE CAPSULE / ORAL AB 2018-06-25 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A204806-001 ATAZANAVIR SULFATE EQ 100MG BASE CAPSULE / ORAL AB 2018-06-25 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A204806-002 ATAZANAVIR SULFATE EQ 150MG BASE CAPSULE / ORAL AB 2018-06-25 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A204806-003 ATAZANAVIR SULFATE EQ 200MG BASE CAPSULE / ORAL AB 2018-06-25 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A204806-004 ATAZANAVIR SULFATE EQ 300MG BASE CAPSULE / ORAL AB 2018-06-25 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A204806-001 ATAZANAVIR SULFATE EQ 100MG BASE CAPSULE / ORAL AB 2018-06-25 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A204806-002 ATAZANAVIR SULFATE EQ 150MG BASE CAPSULE / ORAL AB 2018-06-25 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A204806-003 ATAZANAVIR SULFATE EQ 200MG BASE CAPSULE / ORAL AB 2018-06-25 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A204806-004 ATAZANAVIR SULFATE EQ 300MG BASE CAPSULE / ORAL AB 2018-06-25 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A204806-001 ATAZANAVIR SULFATE EQ 100MG BASE CAPSULE / ORAL AB 2018-06-25 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A204806-002 ATAZANAVIR SULFATE EQ 150MG BASE CAPSULE / ORAL AB 2018-06-25 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A204806-003 ATAZANAVIR SULFATE EQ 200MG BASE CAPSULE / ORAL AB 2018-06-25 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A204806-004 ATAZANAVIR SULFATE EQ 300MG BASE CAPSULE / ORAL AB 2018-06-25 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A204806-001 ATAZANAVIR SULFATE EQ 100MG BASE CAPSULE / ORAL AB 2018-06-25 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A204806-002 ATAZANAVIR SULFATE EQ 150MG BASE CAPSULE / ORAL AB 2018-06-25 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A204806-003 ATAZANAVIR SULFATE EQ 200MG BASE CAPSULE / ORAL AB 2018-06-25 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A204806-004 ATAZANAVIR SULFATE EQ 300MG BASE CAPSULE / ORAL AB 2018-06-25 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A204806-001 ATAZANAVIR SULFATE EQ 100MG BASE CAPSULE / ORAL AB 2018-06-25 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A204806-002 ATAZANAVIR SULFATE EQ 150MG BASE CAPSULE / ORAL AB 2018-06-25 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A204806-003 ATAZANAVIR SULFATE EQ 200MG BASE CAPSULE / ORAL AB 2018-06-25 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A204806-004 ATAZANAVIR SULFATE EQ 300MG BASE CAPSULE / ORAL AB 2018-06-25 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A204806-001 ATAZANAVIR SULFATE EQ 100MG BASE CAPSULE / ORAL AB 2018-06-25 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A204806-002 ATAZANAVIR SULFATE EQ 150MG BASE CAPSULE / ORAL AB 2018-06-25 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A204806-003 ATAZANAVIR SULFATE EQ 200MG BASE CAPSULE / ORAL AB 2018-06-25 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A204806-004 ATAZANAVIR SULFATE EQ 300MG BASE CAPSULE / ORAL AB 2018-06-25 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A204806-001 ATAZANAVIR SULFATE EQ 100MG BASE CAPSULE / ORAL AB 2018-06-25 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A204806-002 ATAZANAVIR SULFATE EQ 150MG BASE CAPSULE / ORAL AB 2018-06-25 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A204806-003 ATAZANAVIR SULFATE EQ 200MG BASE CAPSULE / ORAL AB 2018-06-25 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A204806-004 ATAZANAVIR SULFATE EQ 300MG BASE CAPSULE / ORAL AB 2018-06-25 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A204806-001 ATAZANAVIR SULFATE EQ 100MG BASE CAPSULE / ORAL AB 2018-06-25 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A204806-002 ATAZANAVIR SULFATE EQ 150MG BASE CAPSULE / ORAL AB 2018-06-25 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A204806-003 ATAZANAVIR SULFATE EQ 200MG BASE CAPSULE / ORAL AB 2018-06-25 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A204806-004 ATAZANAVIR SULFATE EQ 300MG BASE CAPSULE / ORAL AB 2018-06-25 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A204806-001 ATAZANAVIR SULFATE EQ 100MG BASE CAPSULE / ORAL AB 2018-06-25 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A204806-002 ATAZANAVIR SULFATE EQ 150MG BASE CAPSULE / ORAL AB 2018-06-25 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A204806-003 ATAZANAVIR SULFATE EQ 200MG BASE CAPSULE / ORAL AB 2018-06-25 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A204806-004 ATAZANAVIR SULFATE EQ 300MG BASE CAPSULE / ORAL AB 2018-06-25 d06236e962d9…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 5 · 164 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 16714-860-01 16714086001 60 CAPSULE in 1 BOTTLE (16714-860-01) 60 capsule 2019-04-08 0000-00-00 No No Current